Tuesday, 02 January 2024 12:17 GMT

Avai Bio Inc


(MENAFN- Baystreet) 11:06 AM EST - Avai Bio Inc: Along with its joint venture partner Austrianova, today announced the first joint steering committee meeting for their collaboration with Ospedale San Raffaele S.r.l., to discuss the initial research program for evaluating an encapsulated beta-cell replacement approach for insulin-dependent diabetes. Avai Bio Inc shares O are trading unchanged at $0.12.

Full Press Release:

MENAFN07102026000212011056ID1111776926



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story